Cipla's market is not India alone and it has to go global, says Yusuf K. Hamied, who stepped down as MD in February C.H. Unnikrishnan Tweet Tweet 0 Subscribe to: Daily Newsletter Breaking News Latest News 12:24 AM IST 12:22 AM IST ... Livemint.com, 3 weeks ago
1 images for "yusuf k hamied"
MUMBAI -- Having made its first foreign acquisition earlier this year, Cipla Ltd, India's second largest drug maker by market share, is planning to go global on the back of its reputation as a maker and supplier of affordable generic drugs to some ...MedCity News, 2 weeks ago Cipla plans bigger global presence [Mint, New Delhi] BusinessWeek, 2 weeks ago
The recent release of the documentary Fire in the Blood has revived the debate on whether patents block access to life-saving medicines. Dr Yusuf K Hamied, chairperson of Cipla and the 'star' of the film, made international headlines in 2001 when he ...Times of India, 1 month ago
K atiyabaaz is a documentary that could have been a feature film. Colourful characters in search of better destinies, their personalities, traits and quirks, conflicts and clashes and triumphs and failures tell a unique, compelling story which ...Outlook India, 1 month ago
AReduce font size AIncrease font size AReduce font size AIncrease font size URL copied to clipboard ApnaCircle My Saved articles RELATED Film: Fire in the Blood Director: Dylan Mohan Gray Cast: Bill Clinton, Zackie Achmat, Peter ...Mumbai Mirror, 2 months ago
Drug maker Cipla plans to shift its strategy, on both markets and products, to address issues on competition and revenue. It has been known for for selling low-priced and for challenging the patents of multinational corporations. Now, it plans to ...Business Standard India, 2 months ago
on your WebpageAdd Widget >Get your members hooked!